Home/Filings/4/A/0001213900-25-030062
4/A//SEC Filing

CHEN THOMAS C 4/A

Accession 0001213900-25-030062

CIK 0001979414other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 9:35 PM ET

Size

16.8 KB

Accession

0001213900-25-030062

Insider Transaction Report

Form 4/AAmended
Period: 2025-03-26
CHEN THOMAS C
DirectorCEO10% Owner
Transactions
  • Sale

    Common Stock

    2025-03-26$19.13/sh983$18,805261,242 total(indirect: By LLC)
  • Exercise of In-Money

    Warrant (right to buy)

    2025-03-2679,6880 total(indirect: By HCWG)
    Exercise: $12.00From: 2025-03-26Common Stock (79,688 underlying)
  • Exercise of In-Money

    Common Stock

    2025-03-26$12.00/sh+79,688$956,256300,475 total(indirect: By LLC)
  • Other

    Common Stock

    2025-03-264,076220,787 total(indirect: By LLC)
  • Sale

    Common Stock

    2025-03-26$25.00/sh38,250$956,250262,225 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By Partnership)
    2,833,961
  • Common Stock

    (indirect: See footnote 4.)
    545,800
  • Common Stock

    (indirect: By Trust)
    93,253
  • Common Stock

    (indirect: By NeuCen Biomedical Co. Ltd.)
    888,148
Footnotes (8)
  • [F1]Transfer of shares of common stock held by HCWG LLC pursuant to agreement.
  • [F2]Not applicable. Number of shares transferred was based on a per share value of $18.
  • [F3]The shares reported herein represent only Reporting Person's percentage interest in HCWG LLC.
  • [F4]On 3/26/2025, in conjunction with Issuer's initial listing on Nasdaq, HCWG exercised a warrant to purchase 312,500 shares of Issuer's common stock at $12 per share. HCWG paid the exercise price on a cashless basis, resulting in Issuer's withholding 150,000 of the warrant shares to pay the exercise price and issuing to HCWG the remaining 162,500 shares of common stock. Number of shares reported herein as acquired and disposed of by the Reporting Person represents Reporting Person's indirect interest in HCWG.
  • [F5]Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
  • [F6]Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
  • [F7]Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
  • [F8]Not applicable.

Issuer

NEONC TECHNOLOGIES HOLDINGS, INC.

CIK 0001979414

Entity typeother

Related Parties

1
  • filerCIK 0001998682

Filing Metadata

Form type
4/A
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 9:35 PM ET
Size
16.8 KB